News

In a new study published in Nature titled, “Custom CRISPR-Cas9 PAM variants via scalable ... sequences while limiting off-target effects. Cas nucleases recognize genomic targets by reading ...
Using systematic screening of actin tail formation in two bacterial strains and employing a panel of CRISPR-CAS ko cell lines ... the authors performed an siRNA screen of interferon-stimulated genes ...
The University of Bayreuth's Biomaterials research group has, for the first time, successfully applied the CRISPR-Cas9 ...
Researchers at Novartis BioMedical Research in the US and Switzerland have identified a molecular target that may provide a ...
In the study, "Targeting the SHOC2–RAS interaction in RAS-mutant cancers," published in Nature, researchers conducted a genome-wide CRISPR screen to identify genetic dependencies associated with ...
The University of California and the University of Vienna on Monday convinced a U.S. appeals court to revive their bid for ...
CRISPR Therapeutics has begun realizing sales on Casgevy, its first therapy and a joint venture with Vertex Pharmaceuticals. The company has plenty of cash to fund research and development for the ...